SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 13.41 |
| Enterprise Value ($M) | 11.81 |
| Book Value ($M) | 4.76 |
| Book Value / Share | 0.24 |
| Price / Book | 2.82 |
| NCAV ($M) | -4.42 |
| NCAV / Share | -0.23 |
| Price / NCAV | -3.03 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.36 |
| Return on Assets (ROA) | -0.55 |
| Return on Equity (ROE) | -4.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.67 |
| Current Ratio | 1.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 13.22 |
| Assets | 22.39 |
| Liabilities | 17.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 59.51 |
| Operating Income | -13.21 |
| Net Income | -15.91 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -5.03 |
| Cash from Investing | 0.20 |
| Cash from Financing | 6.49 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 5.10 | ||
| 13G/A | Empery Asset Management, LP | 1.92 | -59.62 | |
| 13D/A | Starke Clifford | 19.10 | 30.80 | |
| 13D/A | Vaiman Dany | 5.60 | 52.80 | |
| 13G/A | Global X Management CO LLC | 0.00 | -100.00 | |
| 13G | Rds Private Capital Ii, Lp | 9.79 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 33,005 | 248,866 | 13.26 | |
| 23,946 | 116,480 | 20.56 | |
| 74,632 | 180,257 | 41.40 | |
| 8,300 | 82,852 | 10.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FBLG – FibroBiologics, Inc. | FBRX – Forte Biosciences, Inc. |
| FENC – Fennec Pharmaceuticals Inc. | FTLF – FitLife Brands, Inc. |
| GALT – Galectin Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io